Covid-19America's Obesity Epidemic Threatens Effectiveness of Any COVID Vaccine
In the United States, the promise of a vaccine for the coronavirus is hampered by a vexing epidemic that long...
Covid-19Fauci Unfazed as Scientists Rely on Unproven Methods to Create COVID Vaccines
The country's top infectious disease expert said he's "cautiously optimistic" that researchers will develop a COVID-19 vaccine.
Covid-19Public Health Experts Fear a Hasty FDA Signoff on Vaccine
Early evidence that any vaccine works would lead to political pressure from the administration for emergency approval by the FDA.
Covid-19The Color of COVID: Will Vaccine Trials Reflect America's Diversity?
Historically, racial and ethnic miniorities have been less likely to be included in clinical trials for disease treatment.
Covid-19Coronavirus Antibodies Drop Precipitously 3 Months After Mild Cases
UCLA researchers found that the antibodies against SARS-CoV-2 decreased by half every 73 days.
Covid-19A Coronavirus Vaccine: Where Does It Stand?
Kaiser Health News provides a rundown of the vaccine candidates that are furthest along in the clinical phases.
Covid-19Analysis: How a COVID-19 Vaccine Could Cost Americans Dearly
A COVID-19 vaccine will have an actual price tag. And given the prevailing business-centric model of American drug pricing, it...
FinanceBipartisan Bills Aim to Prevent Price Gouging for Taxpayer-funded COVID-19 Drugs
The two pieces of legislation are sponsored by Representatives Jan Schakowsky and Lloyd Doggett.
Covid-19How — and When — Can the Coronavirus Vaccine Become a Reality?
It is likely we'll eventually have a coronavirus vaccine ? but perhaps not as quickly as some expect.
Covid-19Analysis: Get Ready for the Vaccine — They're Never Simple
To determine whether a vaccine prevents disease, the study's subjects need to be exposed to the pathogen as it circulates...
InnovationDr. Patrick Soon-Shiong on Solving COVID-19: 'No Different From Cancer'
The billionaire surgeon-entrepreneur details his plans to use his considerable resources to combat COVID-19.
Covid-19COVID Survivors' Blood Plasma is a Sought-After New Commodity
For-profit companies that typically pay $50 per donation of plasma used in other lifesaving therapies are advertising aggressively ? and...